Ha Young Shin

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism

Sang Won Han, Seo Hyun Kim, Jong Yun Lee et al. · European Neurology · 2006 · 121 citations · Full text

Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice

Kyoung Heo, Yang‐Je Cho, Kyoungjoo Cho et al. · Neuroscience Letters · 2006 · 97 citations · Full text

Kainic Acid, Medicine, Apoptosis +9

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea

Jin Myoung Seok, Hye-Jin Cho, Suk-Won Ahn et al. · Multiple Sclerosis Journal · 2017 · 75 citations · Full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text